Verzenio 50 mg/1

Verzenio 50 mg is a prescription medication used in cancer treatment. This oral tablet, manufactured by Eli Lilly and Company, is designed to target specific cancer cells. Learn more about Verzenio 50 mg uses and effects.

Verzenio 50 mg is primarily used in the treatment of certain types of cancer. It is often prescribed for advanced or metastatic breast cancer, particularly in combination with other therapies. The medication works by targeting specific proteins involved in cancer cell growth. Patients should consult their healthcare provider to understand the specific uses of Verzenio 50 mg for their condition.

Common effects of Verzenio 50 mg may include fatigue, nausea, and diarrhea. Some users may experience a decrease in appetite or hair loss. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects. Always discuss any concerns with a healthcare professional.

Verzenio 50 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using Verzenio 50 mg.

Verzenio 50 mg may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare professional, as it may affect the efficacy or safety of Verzenio 50 mg.